prucalopride succinate

General

Canada-Approved Medicine

This monograph describes a medication approved for use in Canada by the Therapeutic Products Directorate, a division of Health Canada’s Health Products and Food Branch. The medication is not approved by the United States Food and Drug Administration; however, a similar formulation carrying a different generic or brand name might be available in the US.

Pronunciation:
proo-kal-o-pride

Trade Name(s)

  • Resotran Canadian Trade name

Ther. Class.

prokinetic agents

Pharm. Class.

dihydrobenzofurancarboxamides

There's more to see -- the rest of this topic is available only to subscribers.